Your Strength. Our Knowledge and Experience.

Receiving a prostate cancer diagnosis can be overwhelming, and there are important decisions to be made. It’s natural to have questions, and we are here to help you navigate your options and understand what lies ahead. You’ll learn about your cancer care team and what to expect as you embark on this journey.

What Type of Doctor Should You See First After a Prostate Cancer Diagnosis?

Typically, a urologist will perform the biopsy that confirms the presence of prostate cancer and assesses its aggressiveness. Following this initial diagnosis, we recommend scheduling a consultation with an oncologist. Our dedicated oncologists are well-versed in the latest treatment options, ensuring you receive therapies tailored specifically for you.

Your oncologist will help you understand the growth pattern of the cancer and how it may evolve moving forward. The biopsy results, combined with other diagnostic tests, will provide the necessary information to determine both the stage and grade of your prostate cancer.

Staging Prostate Cancer

Using the results from your biopsy and additional diagnostic tests, your oncologist will ascertain the stage of your prostate cancer. Further imaging or scans may be required to identify whether cancer cells have extended beyond the prostate.

Gleason Score and Grading

The Gleason score, included in your biopsy report, indicates how much the cancer cells have altered in various parts of the prostate. This grading aids in determining whether immediate treatment is necessary.

The Gleason score is a system used to grade prostate cancer based on how aggressive and likely it is to spread. It is determined by examining cancer cells under a microscope and assigning them a score from 1 to 5.

Grading:
1-2: Well-differentiated, least aggressive
3-4: Moderately differentiated
5: Poorly differentiated, most aggressive

Gleason scores are subject to interpretation and may vary slightly between pathologists. It is important to discuss your Gleason score with your healthcare provider to understand its implications and treatment options.

Preparing for Your First Oncology Appointment

Your first oncology appointment is essential for gathering important information, but it can be overwhelming. We suggest bringing a notebook or using your smartphone to take notes during the appointment. This will help you keep track of important details and any questions that arise.

We strongly encourage you to bring a friend or loved one for support. They can take notes, ask questions that might be on your mind, and provide reassurance.

Additionally, please bring your health records, including any prostate cancer test results, recent imaging scans, your insurance card, and a list of medications or supplements you’re currently taking.

Questions to Discuss with Your Oncologist

• How soon do I need to decide on a treatment plan?
• If “watchful waiting” is recommended, how often should I return for follow-up testing?
• What treatment options do you suggest when the time comes to proceed?
• What should I expect during future appointments?
• Are there lifestyle changes (in diet, exercise, rest, or stress management) I should consider?
• How should I manage any symptoms affecting my daily life?
• Are there any activities I should avoid or incorporate into my routine?
• Can I take nutritional supplements or vitamins to support my prostate health?
• Should my family and I consider genetic testing to check for hereditary risk?
• What supportive care resources are available through your practice or community organizations?

Feeling confident about your prostate cancer diagnosis and treatment plan is vital, even if it begins with watchful waiting. Many patients choose to seek a second opinion, and our oncologists are completely supportive of this decision. Insurance coverage for second opinions is often available, so we recommend contacting your insurance provider to verify your benefits before scheduling an appointment.

You Are Not Alone on Your Prostate Cancer Journey

At El Portal Comprehensive Cancer Centers, we are committed to supporting you throughout your entire journey. With convenient locations across Central California, we are here to offer you compassionate care and guidance every step of the way. Together, we will navigate this path to achieve the best possible outcome for your health and well-being.

AUTHORIZATION REQUIRED: 

• Alignment Health Plan    
• AllCare IPA Merced (HMO/NO DERM)  
• ALLIANCE (CCAH)
• Anthem MediCAL Managed Care Prog.  
• Brand New Day-Universal Care, Inc.- Medicare 
• Calviva Health 
• Community Care IPA
• California Forensic Medical Group, Inc  
• Health Plan of San Joaquin HMO
• Kova Healthcare, Inc. IPA  
• Imperial Health Medical
• MediCAL  
• Central Valley Medical Providers IPA
• Sequoia Health IPA 
• United Healthcare (AARP)
• Sante Community Physicians  
• Tricare TriWest Healthare
• Alliance  
• Western Growers Assurance Trust  
• Central Valley Pace County Medical Services Program 
• Esperanza IPA- Medicare HMO
• Choice Program
• HealthNet CA- First Health Hill Physicians 
• Humana LaSalle Network Management IPA  
• Meritage Medical Network
• Seven Corners 

NO AUTHORIZATION REQUIRED: 

• Aetna
• Anthem
• Blue Cross of CA  
• Blue Shield of CA
• Medicare 
• UMR ACPN Network-America’s Choice PN  
• First Health Network-Cofinity Galaxy Health Network
• HealthSmart 
• CIGNA
• Anthem ACA Plans- Pathway EPO, PPO 
• BS of CA Promise Health Plan
• Medicare
• Railroad Multiplan/PHCS  
• NaphCare NX Health Network LLC d/b/a Valenz Access 
• Provider Network of America (PNOA)
• Wellcare
• WelbeHealth 

• Verify benefits, plan limits, referral, and pre-authorization requirements before your appointment.
• Bring your insurance card(s).
• Notify us of any insurance or personal information changes immediately.
• Understand your financial responsibility for co-pays, deductibles, and non-covered services.

• We verify and review your benefits.
• We help obtain necessary referrals and authorizations.
• We provide cost estimates.
• We inform you about financial assistance options.
• We bill your primary and, if authorized, secondary insurance.
• For Medicare patients, supervising physician info will be included on your claims.
• Our Financial Counselors can provide resources for you to help navigate obtaining traditional insurance coverage 

• Present your current insurance card at each visit.
• Keep us updated on insurance info.
• Pay co-pays at the time of service.
• Cover any balances remaining after insurance payments.

During Treatment

Receiving a cancer diagnosis can evoke feelings of shock, fear, anger, or uncertainty. The stress of treatment side effects, hospital visits, and lifestyle changes can lead to anxiety and depression. It is normal to experience a wide range of emotions during this time. Maintaining open communication with your healthcare team about your emotional well-being is essential. Psychological support or counseling can provide tools to manage anxiety, depressive symptoms, and emotional distress.

Surviving Cancer

While completing treatment brings relief, many survivors face ongoing emotional challenges such as fear of recurrence, adapting to physical changes, or reintegrating into daily life. Feelings of vulnerability, grief, or identity shifts are common. Building a support network, engaging in self-care, and participating in survivorship programs can foster resilience and emotional strength. Remember, healing is not only physical but also mental and emotional.

Supporting mental health throughout the cancer journey involves accessing appropriate resources:

• Counseling and Therapy: Licensed mental health professionals, including psychologists and social workers, specialize in addressing cancer-related emotional issues. Sessions can offer coping strategies, emotional processing, and support for anxiety or depression.
• Support Groups: Connecting with others who have similar experiences provides comfort, shared knowledge, and a sense of community. Many organizations offer in-person and virtual support groups for patients and caregivers.
• Mind-Body Techniques: Practices such as meditation, yoga, relaxation exercises, or journaling can reduce stress and promote emotional balance.
• Educational Resources: Learning about common emotional reactions to cancer can normalize your experience and provide helpful coping tips. Many cancer centers and organizations offer educational materials or workshops.
• Emergency Support: If you experience severe depression, thoughts of self-harm, or suicidal feelings, seek immediate help by contacting emergency services or going to the nearest emergency room.

Where to Get Help:

• Talk to your healthcare team about mental health concerns; they can refer you to mental health specialists experienced in oncology.
• Contact local mental health clinics or community organizations offering counseling services.
• Utilize national resources like the American Cancer Society’s Reach To Recovery program or the National Alliance on Mental Illness (NAMI).

Breast cancer screening guidelines are designed to help detect breast cancer early when it is most treatable. Here’s an overview of the current recommendations for both women and men.

Breast Cancer Screening Guidelines for Women

Age to Start Screening:

• Ages 40 – 44:Women should have the option to start annual screening mammograms if they choose to do so.
• Ages 45 – 54:Annual mammograms are recommended.
• Ages 55 and Older:Women can transition to biennial (every two years) mammograms, or they may continue annual screening if they prefer. Screening should continue as long as a woman is in good health and has a life expectancy of 10 years or more.
• Clinical Breast Exam: Clinical breast exams by a healthcare provider are no longer universally recommended as part of routine screening but may still be performed based on individual patient needs.

Breast Self-Exam: Regular breast self-exams are not recommended as a primary screening tool, but being familiar with one’s breast tissue can help women notice any changes.

For Women at Higher Risk: Women with a family history of breast cancer, genetic mutations (like BRCA1 or BRCA2), or other risk factors may need to begin screening earlier (often at age 30) and consider additional imaging tests like MRI.

Breast Cancer Screening Guidelines for Men

General Recommendations: Routine screening mammograms are not recommended for men. However, awareness of breast changes is essential, as men can develop breast cancer, though it is rare.

Awareness and Self-Exams: Men should also be aware of their breast tissue and report any changes, such as lumps or changes in appearance, to a healthcare provider.

For Men at Higher Risk: Men with significant family histories of breast cancer or genetic predispositions may require more frequent monitoring and potentially earlier screening.

Summary

Breast cancer screening is crucial for early detection and successful treatment. Women should begin regular screening based on established age guidelines, while men should remain vigilant about changes in their breast tissue, especially if they are at higher risk. It’s essential for individuals to have open discussions with their healthcare providers about personal risk factors and the most appropriate screening protocols for their circumstances.

Lung cancer screening is designed to detect the disease in its early stages when treatment is most effective. Here are the current guidelines for lung cancer screening, focusing primarily on individuals at high risk.

Screening Recommendations

High-Risk Individuals:

• Age:Annual screening is recommended for adults aged 50 to 80
• Smoking History: Individuals with a 30 pack-year smoking history (smoking one pack per day for 30 years, or two packs per day for 15 years) or a comparable history of smoking need to be screened. This includes current smokers and those who have quit within the last 15 years.
• Risk Factors: Individuals with other risk factors, such as a significant family history of lung cancer or exposure to certain carcinogens (like asbestos), may also be considered for screening.
• Screening Method: The primary method recommended for lung cancer screening is low-dose computed tomography (LDCT). This technology uses lower doses of radiation than traditional CT scans and is effective in identifying early-stage lung cancers.
• Screening Intervals: If no cancer is detected, individuals should continue to receive annual LDCT screenings as long as they meet the high-risk criteria.
• Discontinuing Screening: Screening should be discontinued when an individual has not smoked for 15 yearsor if they are no longer in good health and unable to undergo treatment for lung cancer.

Importance of Screening
Lung cancer is often diagnosed at a late stage, which can impact treatment success and survival rates. Early detection through appropriate screening can significantly improve outcomes for high-risk individuals.

Discussing Screening with a Healthcare Provider

It’s essential for individuals who meet the high-risk criteria to have discussions with their healthcare providers about the benefits and risks of lung cancer screening. This conversation should also encompass personal health history and any additional risk factors that may influence the recommendation for screening.

Regular consultations and follow-up evaluations can help ensure that individuals remain informed and proactive about their lung health.

Cervical cancer screening is crucial for early detection and prevention of the disease. Here’s an overview of the current recommendations for cervical cancer screening:

General Recommendations

Age to Start Screening:

• Women Ages 21 to 29: Begin screening with a Pap test(cervical cytology) every 3 years.
• Women Ages 30 to 65: There are two screening options:
• Pap Test Alone: Every 3 years.
• HPV Test Alone: Every 5 years (preferred option).
• Pap and HPV Co-Testing: Every 5 years.

Age to Stop Screening: Women may stop cervical cancer screening at age 65if they have had regular screening with negative results in the past and are not at high risk for cervical cancer.

Frequency of Screening: Screening intervals can vary based on age, past medical history, and the type of test being used. Women should consult with their healthcare provider to determine the best schedule for screening.

Special Considerations

Women with Higher Risk: Women who have a history of cervical cancer, high-grade cervical lesions, or are immunocompromised (e.g., those with HIV) may require more frequent screening, starting earlier and continuing beyond age 65.

Post-Hysterectomy: Women who have undergone a hysterectomy (surgical removal of the uterus and cervix) for non-cancerous reasons typically do not need cervical cancer screening, unless the surgery was done for cervical cancer or pre-cancer.

Vaccination: The HPV vaccine can significantly reduce the risk of cervical cancer. Vaccination is recommended for preteens, but it is also beneficial for young adults who have not been vaccinated.

Importance of Screening

Cervical cancer screening has dramatically reduced cervical cancer rates and mortality through early detection and the ability to identify precancerous changes. Women are encouraged to maintain regular screenings and follow the guidelines to ensure their health and well-being.

Conclusion

Regular cervical cancer screening is an essential part of preventive healthcare for women. Open discussions with healthcare providers can help assess individual risk factors and tailor screening schedules appropriately.

Several screening tests are available, ranging from convenient at-home options to more comprehensive procedures performed at healthcare facilities. Your doctor will work with you to select the best method based on your age and family history.

At-Home Screening Options

These tests allow you to screen in the comfort of your home without extensive preparation, though they may carry risks of false positives.

1. At-Home Testing for Colorectal Cancer: If you are under 50, your physician may recommend at-home testing before scheduling a colonoscopy. This approach lets you complete the test without a day of prior colon preparation. However, it’s essential to note that these tests may overlook some polyps and cancers.
2. Stool DNA Test: Advances in at-home stool testing, such as Cologuard, have made it easier to conduct Fecal Immunochemical Tests (FIT). This simple test checks for blood and genetic changes without requiring extensive dietary changes.
3. Guaiac-based Fecal Occult Blood Test (gFBOT): Another home test prescribed by your doctor, gFBOT identifies hidden blood in the stool. If blood is detected, follow-up with a colonoscopy is typically necessary.

Screening at Healthcare Facilities

Screening procedures conducted in medical facilities are often the most accurate and valuable in colorectal cancer detection, allowing for the immediate removal of any suspicious polyps.

• Standard Colonoscopy: In this procedure, a colonoscope provides detailed images of your colon and allows for tissue removal if abnormalities are found. Proper preparation and sedation are necessary for successful outcomes, and studies show that regular colonoscopies can significantly reduce colorectal cancer mortality rates.
• Virtual Colonoscopy: Utilizing CT imaging to view your colon, this test usually does not require sedation but does involve bowel preparation. If potential issues arise, a standard colonoscopy may follow for confirmation.

When Should You Be Screened for Colorectal Cancer?

The American Cancer Society (ACS) has recently lowered the recommended screening age from 50 to 45 due to rising colorectal cancer rates among younger adults. Contributing factors may include dietary choices, physical inactivity, and obesity.
Recommended screening frequencies vary based on risk levels:

• Average Risk: Adults with no family history of colorectal cancer should undergo screenings every ten years.
• High Risk: Those with a family history, previous inflammatory diseases, or prior radiation exposure to the pelvic area should start screenings earlier and have them more frequently.

Lung cancer screening is designed to detect the disease in its early stages when treatment is most effective. Here are the current guidelines for lung cancer screening, focusing primarily on individuals at high risk.

Screening Recommendations

High-Risk Individuals:

• Age:Annual screening is recommended for adults aged 50 to 80
• Smoking History: Individuals with a 30 pack-year smoking history (smoking one pack per day for 30 years, or two packs per day for 15 years) or a comparable history of smoking need to be screened. This includes current smokers and those who have quit within the last 15 years.
• Risk Factors: Individuals with other risk factors, such as a significant family history of lung cancer or exposure to certain carcinogens (like asbestos), may also be considered for screening.
• Screening Method: The primary method recommended for lung cancer screening is low-dose computed tomography (LDCT). This technology uses lower doses of radiation than traditional CT scans and is effective in identifying early-stage lung cancers.
• Screening Intervals: If no cancer is detected, individuals should continue to receive annual LDCT screenings as long as they meet the high-risk criteria.
• Discontinuing Screening: Screening should be discontinued when an individual has not smoked for 15 yearsor if they are no longer in good health and unable to undergo treatment for lung cancer.

Importance of Screening
Lung cancer is often diagnosed at a late stage, which can impact treatment success and survival rates. Early detection through appropriate screening can significantly improve outcomes for high-risk individuals.

Discussing Screening with a Healthcare Provider

It’s essential for individuals who meet the high-risk criteria to have discussions with their healthcare providers about the benefits and risks of lung cancer screening. This conversation should also encompass personal health history and any additional risk factors that may influence the recommendation for screening.

Regular consultations and follow-up evaluations can help ensure that individuals remain informed and proactive about their lung health.

Prostate cancer screening guidelines are designed to help identify the disease in its early stages when it can be treated more effectively. Here’s an overview of the current recommendations:

Screening Recommendations

Age to Start Screening:

• Men at Average Risk:Screening for prostate cancer using the prostate-specific antigen (PSA) test is generally recommended to begin at age 50.
• Men at High Risk:For those at higher risk, including African American men or those with a family history of prostate cancer, screening may begin earlier, at age 45.
• Risk Factors:

Family History:A strong family history of prostate cancer (e.g., a father or brother diagnosed with the disease).

Ethnicity: African American men are at a higher risk for developing prostate cancer.

Genetic Factors: Inherited genetic mutations, such as BRCA1 or BRCA2, can increase risk.

Discussion of Screening: It is crucial for men to have an informed discussion with their healthcare provider about the risks and benefits of prostate cancer screening, including the potential for false positives and overdiagnosis. This discussion should encompass personal risk factors and overall health status.

Shared decision-making is emphasized to ensure that individuals understand the implications of screening and can make choices that align with their values and preferences.

Screening Methods:

• PSA Test:A blood test measuring the level of prostate-specific antigen. Elevated levels may indicate prostate cancer or other prostate conditions.
• Digital Rectal Examination (DRE):Although less commonly used as a standalone screening tool, a DRE may be performed alongside the PSA test to check for abnormalities in the prostate.

Follow-Up: If screening results indicate elevated PSA levels or if a DRE suggests abnormalities, further evaluation, including a biopsy, may be recommended to confirm the presence of prostate cancer.

Discontinuing Screening: For men over age 70or those with less than a 10-year life expectancy due to other health issues, the benefits of continuing routine screening may not outweigh the risks. Discussions around stopping screening should be had with healthcare providers.

Summary

Prostate cancer screening is an important health consideration for men, particularly those at higher risk. Open communication with healthcare providers can help guide decisions about when to start screening and how to proceed based on individual circumstances.

Pancreatic cancer is often diagnosed at an advanced stage, making early detection challenging. As a result, screening guidelines focus primarily on high-risk individuals rather than the general population. Here’s an overview of current recommendations for pancreatic cancer screening:

General Recommendations

• High-Risk Individuals: Screening for pancreatic cancer is recommended primarily for individuals at high risk due to specific factors:
• Family History: A strong family history of pancreatic cancer or other associated cancers (e.g., breast, ovarian, or colorectal cancer) may heighten risk. Individuals with genetic syndromes, such as BRCA2mutations, Lynch syndrome, or familial atypical multiple-mole melanoma syndrome (FAMMM), are also at increased risk.
• Chronic Pancreatitis:Long-standing inflammation of the pancreas can elevate the risk of developing cancer.
• Age and Testing: For individuals at high risk, screening usually begins between ages 40 and 50, depending on individual risk factors and family history.
• Women with BRCA mutations may start screening at age 50or younger.

Screening Methods

Imaging Tests:

• MRI (Magnetic Resonance Imaging) or Endoscopic Ultrasound (EUS): These imaging techniques are the most commonly used for pancreas cancer screening in high-risk individuals. They provide detailed images of the pancreas and can help identify cysts or tumors.
• Biomarker Testing: Research is ongoing to identify blood markers associated with pancreatic cancer, but as of now, there are no established routine blood tests for screening.

Follow-Up and Risk Management

• Regular Monitoring: Individuals at high risk should undergo regular screening every 1 to 2 years, depending on their healthcare provider’s recommendations and findings from previous screenings.
• Genetic Counseling: For individuals with a strong family history or genetic predisposition, genetic counseling can provide insights and may help guide decision-making regarding screening and preventive measures.

Conclusion

Because of the aggressive nature of pancreatic cancer and its often late-stage diagnosis, screening is primarily targeted at those identified as high risk. If you have concerns about your risk for pancreatic cancer, it’s essential to discuss them with your healthcare provider, who can help assess your risk and establish an appropriate screening plan.

Most colorectal cancers are detected during routine screenings, which have become more streamlined, making it easier for you to stay on track with your health. It’s essential to know the types of tests available for early detection of colorectal cancer.

1. Colonoscopy: This procedure involves using a long, flexible tube with a camera to examine the entire colon and rectum. It’s the most comprehensive screening method and allows for the removal of polyps during the exam.
2. Flexible Sigmoidoscopy: Similar to a colonoscopy but examines only the rectum and the lower part of the colon. It requires less preparation and can be done in a doctor’s office.
3. Fecal Occult Blood Test (FOBT): This non-invasive test checks for hidden blood in the stool, which can be a sign of cancer or polyps. It usually requires multiple stool samples over several days.
4. Fecal Immunochemical Test (FIT): Another stool test that detects blood in the stool using antibodies. It’s more specific than the FOBT and does not require dietary restrictions.
5. CT Colonography (Virtual Colonoscopy): This imaging test uses X-rays and computer technology to create detailed pictures of the colon. It’s less invasive than a traditional colonoscopy but cannot remove polyps.
6. DNA Stool Test: This test analyzes stool samples for specific DNA markers that may indicate the presence of cancer or pre-cancerous conditions. It can be more comprehensive in its approach.
7. Blood Tests: While not used for routine screening, certain blood tests may help assess liver function or detect tumor markers in some cases.

These tests help identify colorectal cancer or pre-cancerous polyps early when treatment is most effective. It’s important to discuss with a healthcare provider which screening method is best suited for individual risk factors and medical history.

Plainly put: Regular screening can save lives!

During the early stages of colorectal cancer, there are typically no visible signs of its presence, making screenings crucial for identifying pre-cancerous and cancerous areas while they are still small. Early detection often leads to fewer treatment demands and greatly increases success rates.

Although it might feel uncomfortable, please don’t shy away from scheduling your screening, especially if you are over 40. Taking this step with your primary care physician can help you create a personalized colon cancer screening plan that is right for you.

Like many cancers, various factors influence your risk of developing colorectal cancer—some of which are controllable and others that are not. While no one can predict with certainty if or when colorectal cancer will arise, educating yourself about these risk factors can empower you to take proactive measures to reduce your likelihood of diagnosis.

By staying informed and proactive, you can play an essential role in your health journey and work towards minimizing your risk of colorectal cancer. At El Portal Comprehensive Cancer Centers, we are here to support you with expertise and compassion every step of the way.